Literature DB >> 27224274

Medicinal Plants and Natural Products as Potential Sources for Antiparkinson Drugs.

José-Luis Ríos1, María Onteniente1, Dolores Picazo1, María-Carmen Montesinos1.   

Abstract

Parkinson's disease is a progressive neurodegenerative dysfunction characterized by the loss of pigmented dopaminergic neurons of the nigrostriatal system with a consequent dopamine decrease. The reduction of dopamine levels produces neuronal damage, depigmentation of the substantia nigra, and the presence of intracellular inclusions in dopaminergic neurons. Treatments for Parkinson's disease aim for improving these motor symptoms by increasing the dopaminergic signal in the striatum with levodopa in combination with enzyme inhibitors or anticholinergic drugs. Nevertheless, natural products can act as neuroprotective agents by reducing the progression of the disease and the inflammatory process.In the present review, we have compiled data on the principal medicinal plants and natural products as potential antiparkinsonian agents. They act by different mechanisms, such as the inhibition of α-synuclein condensation, reduction of oxidative stress and neuro-inflammation, increase of dopaminergic neurons survival, or the blockade of the A2 A receptor. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27224274     DOI: 10.1055/s-0042-107081

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  7 in total

Review 1.  Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives.

Authors:  Khosro Jamebozorgi; Eskandar Taghizadeh; Daryoush Rostami; Hosein Pormasoumi; George E Barreto; Seyed Mohammad Gheibi Hayat; Amirhossein Sahebkar
Journal:  Mol Neurobiol       Date:  2018-11-05       Impact factor: 5.590

2.  Garcinol blocks motor behavioural deficits by providing dopaminergic neuroprotection in MPTP mouse model of Parkinson's disease: involvement of anti-inflammatory response.

Authors:  Banashree Chetia Phukan; Ankumoni Dutta; Satarupa Deb; Rubul Saikia; Muhammed Khairujjaman Mazumder; Rajib Paul; Pallab Bhattacharya; Rajat Sandhir; Anupom Borah
Journal:  Exp Brain Res       Date:  2021-10-11       Impact factor: 1.972

3.  Test for Non-Synergistic Interactions in Phytomedicine, Just as You Do for Isolated Compounds.

Authors:  Areeba Patel; Farooq Ali Khan; Arindam Sikdar; Amit Mondal; Sunil Dutt Shukla; Sukant Khurana
Journal:  J Exp Neurosci       Date:  2018-04-18

Review 4.  Phytochemistry and pharmacological activity of the genus artemisia.

Authors:  Dheeraj Bisht; Deepak Kumar; Dharmendra Kumar; Kamal Dua; Dinesh Kumar Chellappan
Journal:  Arch Pharm Res       Date:  2021-04-24       Impact factor: 6.010

5.  Dose Dependent Effects of Breynia cernua Against the Paraquat Induced Parkinsonism like Symptoms in Animals' Model: In Vitro, In Vivo and Mechanistic Studies.

Authors:  Malik Saadullah; Sania Arif; Liaqat Hussain; Muhammad Asif; Umair Khurshid
Journal:  Dose Response       Date:  2022-09-09       Impact factor: 2.623

Review 6.  Conifers Phytochemicals: A Valuable Forest with Therapeutic Potential.

Authors:  Kanchan Bhardwaj; Ana Sanches Silva; Maria Atanassova; Rohit Sharma; Eugenie Nepovimova; Kamil Musilek; Ruchi Sharma; Mousa A Alghuthaymi; Daljeet Singh Dhanjal; Marcello Nicoletti; Bechan Sharma; Navneet Kumar Upadhyay; Natália Cruz-Martins; Prerna Bhardwaj; Kamil Kuča
Journal:  Molecules       Date:  2021-05-18       Impact factor: 4.411

Review 7.  Natural Products in Modulating Methamphetamine-Induced Neuronal Apoptosis.

Authors:  Yiwei Zeng; Yunhui Chen; Su Zhang; Huan Ren; Jialin Xia; Mengnan Liu; Baozhi Shan; Yulan Ren
Journal:  Front Pharmacol       Date:  2022-01-04       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.